Bill
Bill > HB1182
VA HB1182
VA HB1182Health insurance; coverage for contraceptive drugs & devices, including over-the-counter.
summary
Introduced
01/14/2026
01/14/2026
In Committee
03/09/2026
03/09/2026
Crossed Over
03/11/2026
03/11/2026
Passed
03/30/2026
03/30/2026
Dead
Introduced Session
Potential new amendment
2026 Regular Regular Session
Bill Summary
Health insurance; coverage for contraceptive drugs and devices. Requires health insurance carriers to provide coverage, under any health insurance contract, policy, or plan that includes coverage for prescription drugs on an outpatient basis, for contraceptive drugs and contraceptive devices approved by the U.S. Food and Drug Administration, including those available over-the-counter. The bill prohibits a health insurance carrier from imposing upon any person receiving prescription contraceptive benefits pursuant to the provisions of the bill any copayment, coinsurance payment, or fee, except in certain circumstances. Additionally, the bill requires any health benefit plan that provides coverage for hormonal contraceptives to provide point-of-sale coverage without cost-sharing at in-network pharmacies for hormonal contraceptives available over-the-counter. This bill is identical to SB 361.
AI Summary
This bill requires health insurance carriers in Virginia to provide coverage for contraceptive drugs and devices, including those available over-the-counter, under any health insurance plan that covers prescription drugs. The bill defines "contraceptive device" and "contraceptive drug" as those approved by the FDA (U.S. Food and Drug Administration), and also defines "medical need" to allow for exceptions to cost-sharing based on a healthcare provider's recommendation. It prohibits insurers from imposing copayments, coinsurance, or fees on contraceptive benefits, except in specific circumstances, and mandates that health benefit plans provide point-of-sale coverage without cost-sharing at in-network pharmacies for over-the-counter hormonal contraceptives. The bill also clarifies that it does not require coverage for plans that don't already cover prescription drugs or for experimental contraceptives not approved by the FDA, and specifies that these provisions will apply to policies delivered, issued for delivery, or renewed on or after January 1, 2027.
Committee Categories
Budget and Finance, Business and Industry
Sponsors (54)
Josh Thomas (D)*,
Kimberly Adams (D),
Jessica Anderson (D),
Bonita Anthony (D),
Alex Askew (D),
Elizabeth Bennett-Parker (D),
Gretchen Bulova (D),
Katrina Callsen (D),
Kacey Carnegie (D),
Betsy Carr (D),
Stacey Carroll (D),
Laura Jane Cohen (D),
Joshua Cole (D),
Nicole Cole (D),
Kelly Convirs-Fowler (D),
Rae Cousins (D),
Karrie Delaney (D),
Lindsey Dougherty (D),
Mark Downey (D),
Michael Feggans (D),
Lily Franklin (D),
Margaret Franklin (D),
Debra Gardner (D),
Jackie Glass (D),
Elizabeth Guzmán (D),
C.E. Hayes (D),
Dan Helmer (D),
J.R. Henson (D),
Phil Hernandez (D),
Charniele Herring (D),
Karen Keys-Gamarra (D),
Paul Krizek (D),
Amy Laufer (D),
Destiny LeVere Bolling (D),
Michelle Lopes-Maldonado (D),
Alfonso Lopez (D),
Adele McClure (D),
Garrett McGuire (D),
Delores McQuinn (D),
Leslie Chambers Mehta (D),
Marcia Price (D),
Sam Rasoul (D),
Atoosa Reaser (D),
Charlie Schmidt (D),
Holly Seibold (D),
Briana Sewell (D),
Marcus Simon (D),
Shelly Simonds (D),
Richard Sullivan (D),
Virgil Thornton (D),
Kathy Tran (D),
Jeion Ward (D),
Vivian Watts (D),
Rodney Willett (D),
Last Action
Governor's recommendation received by House (on 04/11/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...